USPatentGranted
A

Preparation of N-substituted piperazinones

Granted 30 Aug 1988 · no office action yet

Current assignee: The Dow Chemical · originally DuPont

Law firm: Law firm · Log in to unlock

Attorney: Attorney · Log in to unlock

Inventors: Kevin C. Taylor, Brian W. S. Kolthammer, Gordon C. Dunmore · Examiner: Glennon H. Hollrah · AU 129 · TC 1200

Application
917861
filed 14 Oct 1986
Publication
Not published
not published
Patent· this page
US 4,767,860
granted 30 Aug 1988

Life of the patent

2 dated events
⤢ drag to zoomOct 1986Jan 1987Apr 1987Jul 1987Oct 1987Jan 1988Apr 1988Jul 1988Oct 1988Prosecution
Prosecutionhover for detail · click to open

Abstract

N-substituted piperazinones are prepared by reacting an N-substituted ethylenediamine such as N,N\'-dimethylethylenediamine with a 2-oxoaldehyde such as glyoxal. N-substituted piperazinones are useful as flue gas desulfurization agents.

Description

9 parts
›BACKGROUND OF THE INVENTION

This invention relates to the preparation of N-substituted piperazinones. More specifically, it pertains to a process for preparing N-substituted piperazinones by reacting a substituted diamine with an aldehyde.

The piperazinones prepared by this invention are useful as catalysts for the hydrolysis of carbon oxysulfide which is a toxic contaminant found in petroleum refinery gases and coal gasification product streams. Piperazinones are also useful for extracting hydrogen sulfide and lower alkyl mercaptans from various industrial gas streams. Piperazinones have further been found to be powerful stabilizers for materials subject to ultraviolet light degradation.

There exists several methods for the preparation of N-substituted piperazinones. U.S. Pat. No. 2,649,450 describes a process wherein a carbonyl compound, hydrogen cyanide and an ethylenediamine are reacted in the presence of water to yield a 1,4-dialkylpiperazin-2-one. This process is disadvantageous in that it requires the use of highly toxic hydrogen cyanide. The intermediate cyanohydrin of this process is also slow to rearrange to the final product.

U.S. Pat. No. 4,167,512 describes two syntheses for preparing poly-substituted 2-keto-1,4-diazacycloalkanes. One synthesis involves reacting a 1,2-diamine with a cyanohydrin in the presence of an organic solvent, an aqueous alkali, an onium salt catalyst and a haloform. The other method disclosed in U.S. Pat. No. 4,167,512 involves reacting a 1,2-diamine with a monoketone or monoaldehyde and a haloform reactant in the presence of an organic solvent, an aqueous alkali and an onium salt catalyst. These syntheses are disadvantageous in that the intermediates produced in these syntheses require severe conditions for conversion to the desired products. Thus, these syntheses are not as economical as desired.

What is needed is a toxic-free and straightforward process for preparing N-substituted piperazinones in a high yield. Such a process would allow the efficient production of N-substituted piperazinones which are useful in the removal of toxic contaminants from various industrial gases. The piperazinones so produced could also be used as stabilizers for materials susceptible to ultraviolet light degradation.

›SUMMARY OF THE INVENTION

The present invention is a facile, high yield process for the production of N-substituted piperazinones. The process of the present invention comprises contacting an N-substituted ethylenediamine with a 2-oxoaldehyde in proportions and under reaction conditions sufficient to produce an N-substituted piperazinone.

The present process avoids the use of hydrogen cyanide and proceeds rapidly under the reaction conditions described herein. The N-substituted piperazinones are produced in high yield and purity by the process of the present invention.

›DETAILED DESCRIPTION OF THE INVENTION

The process of the present invention comprises contacting an N-substituted ethylenediamine and a 2-oxoaldehyde in proportions and under reaction conditions sufficient to produce an N-substituted piperazinone.

The N-substituted ethylenediamines useful in the present invention must be substituted at one of the N positions and can be substituted at the other N position and at the C position. Preferred substituted ethylenediamines of the present invention correspond to the following general formula: ##STR1## wherein R 1 , R 2 , R 3 , R 4 , R 5 and R 6 independently can be hydrogen, a hydrocarbon chain or ring of from 1 to 9 carbon atoms, aryl, arylalkyl or alkylaryl with the proviso that R 1 and R 6 cannot both be hydrogen and that R 2 and R 4 and/or R 3 and R 5 in combination with the ethylene moiety to which R 2 , R 4 , R 3 and R 5 are bonded can form a hydrocarbon ring of from 5 to 7 carbon atoms.

Preferred substituted ethylenediamines include N-methylethylenediamine, N-ethylethylenediamine, N,N'-dimethylethylenediamine, N,N'-diethylethylenediamine, N,N'-di(n-propyl)ethylenediamine, N,N'-di(n-butyl)ethylenediamine, N,N'-di(t-butyl)ethylenediamine, and N,N'-dihexylethylenediamine. N,N'-dimethylethylenediamine is the most preferred ethylenediamine.

Any 2-oxoaldehyde which will react sufficiently with an N-substituted ethylenediamine of the present invention to form an N-substituted piperazinone can be utilized in the present process. Preferred 2-oxoaldehydes of this invention correspond to the following general formula: ##STR2## wherein R 7 can be hydrogen or a hydrocarbon chain or ring of from 1 to 9 carbon atoms, aryl, arylalkyl or alkylaryl, with the 2-oxoaldehydes wherein R 7 is alkyl or hydrogen being more preferred.

Examples of more preferred 2-oxoaldehydes include glyoxal, methylglyoxal, ethylglyoxal and propylglyoxal. Glyoxal is the most preferred.

The 2-oxoaldehyde may be employed in any amount sufficient to react with the N-substituted ethylenediamine such that the desired N-substituted piperazinone is produced. The molar ratio of 2-oxoaldehyde to N-substituted ethylenediamine is preferably in the range from about 1 to about 5, more preferably from about 1 to about 2 and most preferably is about 1.1.

Although not required, a solvent is advantageously employed in the practice of the present invention. An solvent which will dissolve both reactants can be utilized in the practice of the present invention. Typical solvents include ethers such as diethyl ether, alcohols such as methanol and ethanol, and water with water and methanol being preferred. Water is the most preferred solvent.

Any amount of solvent sufficient to dilute the reactants to allow bimolecular cyclization to occur preferentially can be utilized in the present process. Preferred molar ratios of solvent to N-substituted ethylenediamine are in the range from about 50 to about 1000, more preferably from about 100 to about 200, with 150 being most preferred.

The reaction can be carried out at any temperature and pressure sufficient to form the N-substituted piperazinone. Suitable temperatures are in the range from about 50° C. to about 110° C., preferably from about 90° C. to about 100° C. Sub- or super-atmospheric pressures can be utilized with ambient pressure being preferred for convenience.

The product can be separated by well-known distillation techniques and is advantageously produced in yields greater than about 30 percent, preferably greater than 90 percent.

The process of the present invention can be represented by the following general scheme ##STR3## wherein R 1 -R 7 are as defined hereinbefore.

N-substituted piperazinones prepared by this invention include 1,4-dimethylpiperazin-2-one, 1,4-diethylpiperazin-2-one, 1,4-di(n-propyl)piperazin-2-one, 1,4-di(n-butyl)piperazin-2-one and 4-methylpiperazin-2-one and 1,3,4-trimethylpiperazin-2-one.

›SPECIFIC EMBODIMENTS

The following examples are given for illustrative purposes only and are not intended to limit the scope of the claims. All parts and percentages are by weight unless otherwise indicated.

›Examples5
›EXAMPLE 1

To 10 g (69.0 mmoles) of 40 percent glyoxal and 200 ml of distilled water is rapidly added 6.1 g (69.0 mmoles) of N,N'-dimethylethylenediamine. The solution is heated rapidly to reflux and heating maintained for 5 minutes. The dark brown solution is allowed to cool to room temperature and is then evaporated at 60° C. under water pump vacuum to a viscous brown oil. The oil is distilled in a short path distillation apparatus to yield 8.2 g (93 percent yield) of 1,4-dimethylpiperazin-2-one in the form of a yellow oil. Purity is greater than 99 percent by capillary gas chromatograph.

›EXAMPLE 2

To 10.0 g (69.0 mmoles) of 40 percent glyoxal and 200 ml of distilled water is rapidly added 8.0 g (69.0 mmoles) of N,N'-diethylethylenediamine. The solution is heated rapidly to reflux and heating maintained for 5 minutes. The dark brown solution is allowed to cool to room temperature and is then evaporated at 60° C. under water pump vacuum to a viscous brown oil. The oil is distilled in a short path distillation apparatus to yield 10 g (93 percent yield) of 1,4-diethylpiperazin-2-one in the form of a yellow oil. Purity is greater than 99 percent by capillary gas chromatograph.

›EXAMPLE 3

To 10.0 g (69.0 mmoles) of 40 percent glyoxal and 200 ml of distilled water is rapidly added 9.94 g (69.0 mmoles) of N,N'-di(n-propyl)ethylenediamine. The solution is heated rapidly to reflux and heating maintained for 5 minutes. The dark brown solution is allowed to cool to room temperature and is then evaporated at 60° C. under water pump vacuum to a viscous brown oil. The oil is distilled in a short path distillation apparatus to yield 9.3 g (73 percent yield) of a yellow oil. Purity is greater than 99 percent of 1,4-di(n-propyl)piperazin-2-one as determined by capillary gas chromatograph.

›EXAMPLE 4

To 10 g (69.0 mmoles) of 40 percent glyoxal and 200 ml of methanol is rapidly added 11.9 g (69.0 mmoles) of N,N'-di(n-butyl)ethylenediamine. The solution is rapidly brought to reflux and heating is maintained for 5 minutes. The dark brown solution is then allowed to cool to room temperature at which time fine white crystals precipitate from the brown oil. The oil is diluted with 100 ml of 1,4-dioxane and the solid is removed by filtration. The dioxane solution is concentrated under aspirator vacuum and distilled in a short path distillation apparatus to give 4.5 g of 1,4-di(n-butyl)piperazin-2-one in the form of a brown oil (31 percent yield).

›EXAMPLE 5

To 10.0 g (69.0 mmoles) of 40 percent glyoxal and 200 ml of distilled water is rapidly added 5.0 g (69.0 mmoles) of N-methylethylenediamine. The solution is heated rapidly to reflux and heating maintained for 5 minutes. The dark brown solution is allowed to cool to room temperature and is then evaporated at 60° C. under water pump vacuum. After removal of water, 3.62 g (46 percent yield) of 4-methyl-2-piperazinone (yellow crystals) are obtained by vacuum sublimation. Purity is greater than 99 percent by capillary gas chromatograph.

Claims

11 · 3 independent · depth 9
1234567891011
11 granted claims

Classifications

3 codes
IPC · International Patent Classification
Section C — Chemistry; metallurgy
  • C07D241/08
USPC · US Patent Classification
544/384544/354

Claim changes

Soon
Coming soonHow the claims changed between publication and grant

See which claims were amended, added or cancelled during examination, with every added and removed word marked.

AmendedAddedCancelledUnchanged

The published claims of this patent are not paired with the granted ones in what we hold.

File wrapper

Pendency
1.9 y
686 days filing → grant
Office actions
0
on the grant's record
Examiner
Glennon H. Hollrah
art unit 129 · TC 1200
Citations: 20 back · 8 forward

Chain of title

⤢ drag to zoom1988199019921994199619982000200220042006Owner 1
Titlehover for detail · click to open

See the full assignment history — every owner this patent has passed through, with recordation dates and reel/frame numbers.

Log in to unlock

Term & fees

See the term timeline — pendency span, in-force span, the maintenance fees paid and both computed expiry dates.

Log in to unlock

Worldwide family

15 members · 11 offices
US1EP2JP1KR1CN1AU2CA1DK2MX1NO2NZ1
this patentIP5 & PCTother officessolid = grantedhover for detail · click to open
Members
15
DOCDB simple family 25439429
Offices
11
US · EP · JP · KR · CN
Granted
3 of 15
grant date present
Non-English titles
9
shown as filed, never translated
›IP5 & PCT — 6 members
OfficePublicationKindPublishedFiledStatusTitle
USthis patentUS-4767860-AA30 Aug 198814 Oct 1986grantedPreparation of N-substituted piperazinones
EPEP-0264261-A2A220 Apr 198813 Oct 1987publishedPréparation de pipérazinones N-substituéesfr
EPEP-0264261-A3A328 Feb 199013 Oct 1987publishedPréparation de pipérazinones N-substituéesfr
JPJP-S63152365-AA24 Jun 198814 Oct 1987publishedProduction of n-substituted piperadinone
KRKR-880005100-AA28 Jun 198814 Oct 1987publishedN-치환된 피페라진논의 제조방법ko
CNCN-87107783-AA24 Aug 198813 Oct 1987published二氧化硫转化或还原成元素硫的工艺zh
›Other offices — 9 members
OfficePublicationKindPublishedFiledStatusTitle
AUAU-7958987-AA21 Apr 198813 Oct 1987publishedPreparation of n-substituted piperazinones
AUAU-615636-B2B210 Oct 199113 Oct 1987grantedPreparation of n-substituted piperazinones
CACA-1277987-CC18 Dec 199013 Oct 1987grantedPreparation of n-substituted piperazinones
DKDK-537687-D0D014 Oct 198714 Oct 1987publishedFremgangsmaade til fremstilling af n-substituerede piperazinonerda
DKDK-537687-AA15 Apr 198814 Oct 1987publishedFremgangsmaade til fremstilling af n-substituerede piperazinonerda
MXMX-166109-BB21 Dec 199214 Oct 1987publishedPreparacion de piperacinonas n-sustituidases
NONO-874268-D0D013 Oct 198713 Oct 1987publishedFremgangsmaate for fremstilling av n-substituerte piperazinoner.no
NONO-874268-LL15 Apr 198813 Oct 1987publishedFremgangsmaate for fremstilling av n-substituerte piperazinoner.no
NZNZ-222131-AA29 Jan 199112 Oct 1987publishedPreparation of n-substituted piperazinones

Validity challenges

See the validity challenges on record — reexaminations, IPRs and PGRs, with their institution decisions and outcomes.

Log in to unlock

Citations

See every patent this one cites and every patent that cites it back — publication, assignee, and how each one was found.

Log in to unlock